Click for best price
OverTheCounterOTC Drugs Market Size, Share 2022
Market Analysis and Insights: Global OverTheCounterOTC Drugs Market
The global OverTheCounterOTC Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global OverTheCounterOTC Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global OverTheCounterOTC Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global OverTheCounterOTC Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global OverTheCounterOTC Drugs market.
Global OverTheCounterOTC Drugs Scope and Market Size
Over-The-Counter(OTC) Drugs market is segmented by Type and by Sale Channel. Players, stakeholders, and other participants in the global Over-The-Counter(OTC) Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Sale Channel for the period 2017-2028.
Segment by Type
Cold and Flu Products
Analgesics
Dermatological Products
Gastrointestinal Products
Vitamin
Other
Segment by Sale Channel
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
By Company
Bayer
Boehringer Ingelheim
GSK
Novartis
Pfizer
PGT healthcare
Sanofi
Teva Pharmaceuticals
Takeda
Cipla
Sun Pharmaceutical Industries
Glenmark
Innovus Pharmaceuticals
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The information for each competitor/Company Profile includes:
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
The content of the study subjects includes a total of 15 chapters:
Chapter 1, describes OverTheCounterOTC Drugs product scope, market overview, market opportunities, market driving force, and market risks.
Chapter 2, profiles the top manufacturers of OverTheCounterOTC Drugs, with price, sales, revenue, and global market share of OverTheCounterOTC Drugs from 2019 to 2022.
Chapter 3, the OverTheCounterOTC Drugs competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the OverTheCounterOTC Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.
Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the OverTheCounterOTC Drugs market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of OverTheCounterOTC Drugs.
Chapter 13, 14, and 15, to describe OverTheCounterOTC Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Key Indicators Analysed:
- Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
- Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
- Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
- Opportunities and Drivers: Identifying the Growing Demands and New Technology
- Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Reasons to Purchase this Report:
- Estimates 2022-2027 2021-2025 OverTheCounterOTC Drugs Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
- 1-year analyst support, along with the data support in excel format.
Research Methodology:
The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.
| Report Attributes |
Report Details |
| Report Title |
Global Over-The-Counter(OTC) Drugs Market Insights and Forecast to 2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
107 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Study Coverage
1.1 Over-The-Counter(OTC) Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Over-The-Counter(OTC) Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Cold and Flu Products
1.2.3 Analgesics
1.2.4 Dermatological Products
1.2.5 Gastrointestinal Products
1.2.6 Vitamin
1.2.7 Other
1.3 Market by Sale Channel
1.3.1 Global Over-The-Counter(OTC) Drugs Market Size Growth Rate by Sale Channel, 2017 VS 2021 VS 2028
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Over-The-Counter(OTC) Drugs Sales Estimates and Forecasts 2017-2028
2.2 Global Over-The-Counter(OTC) Drugs Revenue Estimates and Forecasts 2017-2028
2.3 Global Over-The-Counter(OTC) Drugs Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Over-The-Counter(OTC) Drugs Sales by Region
2.4.1 Global Over-The-Counter(OTC) Drugs Sales by Region (2017-2022)
2.4.2 Global Sales Over-The-Counter(OTC) Drugs by Region (2023-2028)
2.5 Global Over-The-Counter(OTC) Drugs Revenue by Region
2.5.1 Global Over-The-Counter(OTC) Drugs Revenue by Region (2017-2022)
2.5.2 Global Over-The-Counter(OTC) Drugs Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Over-The-Counter(OTC) Drugs Sales by Manufacturers
3.1.1 Global Top Over-The-Counter(OTC) Drugs Manufacturers by Sales (2017-2022)
3.1.2 Global Over-The-Counter(OTC) Drugs Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Over-The-Counter(OTC) Drugs in 2021
3.2 Global Over-The-Counter(OTC) Drugs Revenue by Manufacturers
3.2.1 Global Over-The-Counter(OTC) Drugs Revenue by Manufacturers (2017-2022)
3.2.2 Global Over-The-Counter(OTC) Drugs Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Over-The-Counter(OTC) Drugs Revenue in 2021
3.3 Global Over-The-Counter(OTC) Drugs Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Over-The-Counter(OTC) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Over-The-Counter(OTC) Drugs Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Over-The-Counter(OTC) Drugs Sales by Type
4.1.1 Global Over-The-Counter(OTC) Drugs Historical Sales by Type (2017-2022)
4.1.2 Global Over-The-Counter(OTC) Drugs Forecasted Sales by Type (2023-2028)
4.1.3 Global Over-The-Counter(OTC) Drugs Sales Market Share by Type (2017-2028)
4.2 Global Over-The-Counter(OTC) Drugs Revenue by Type
4.2.1 Global Over-The-Counter(OTC) Drugs Historical Revenue by Type (2017-2022)
4.2.2 Global Over-The-Counter(OTC) Drugs Forecasted Revenue by Type (2023-2028)
4.2.3 Global Over-The-Counter(OTC) Drugs Revenue Market Share by Type (2017-2028)
4.3 Global Over-The-Counter(OTC) Drugs Price by Type
4.3.1 Global Over-The-Counter(OTC) Drugs Price by Type (2017-2022)
4.3.2 Global Over-The-Counter(OTC) Drugs Price Forecast by Type (2023-2028)
5 Market Size by Sale Channel
5.1 Global Over-The-Counter(OTC) Drugs Sales by Sale Channel
5.1.1 Global Over-The-Counter(OTC) Drugs Historical Sales by Sale Channel (2017-2022)
5.1.2 Global Over-The-Counter(OTC) Drugs Forecasted Sales by Sale Channel (2023-2028)
5.1.3 Global Over-The-Counter(OTC) Drugs Sales Market Share by Sale Channel (2017-2028)
5.2 Global Over-The-Counter(OTC) Drugs Revenue by Sale Channel
5.2.1 Global Over-The-Counter(OTC) Drugs Historical Revenue by Sale Channel (2017-2022)
5.2.2 Global Over-The-Counter(OTC) Drugs Forecasted Revenue by Sale Channel (2023-2028)
5.2.3 Global Over-The-Counter(OTC) Drugs Revenue Market Share by Sale Channel (2017-2028)
5.3 Global Over-The-Counter(OTC) Drugs Price by Sale Channel
5.3.1 Global Over-The-Counter(OTC) Drugs Price by Sale Channel (2017-2022)
5.3.2 Global Over-The-Counter(OTC) Drugs Price Forecast by Sale Channel (2023-2028)
6 North America
6.1 North America Over-The-Counter(OTC) Drugs Market Size by Type
6.1.1 North America Over-The-Counter(OTC) Drugs Sales by Type (2017-2028)
6.1.2 North America Over-The-Counter(OTC) Drugs Revenue by Type (2017-2028)
6.2 North America Over-The-Counter(OTC) Drugs Market Size by Sale Channel
6.2.1 North America Over-The-Counter(OTC) Drugs Sales by Sale Channel (2017-2028)
6.2.2 North America Over-The-Counter(OTC) Drugs Revenue by Sale Channel (2017-2028)
6.3 North America Over-The-Counter(OTC) Drugs Market Size by Country
6.3.1 North America Over-The-Counter(OTC) Drugs Sales by Country (2017-2028)
6.3.2 North America Over-The-Counter(OTC) Drugs Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Over-The-Counter(OTC) Drugs Market Size by Type
7.1.1 Europe Over-The-Counter(OTC) Drugs Sales by Type (2017-2028)
7.1.2 Europe Over-The-Counter(OTC) Drugs Revenue by Type (2017-2028)
7.2 Europe Over-The-Counter(OTC) Drugs Market Size by Sale Channel
7.2.1 Europe Over-The-Counter(OTC) Drugs Sales by Sale Channel (2017-2028)
7.2.2 Europe Over-The-Counter(OTC) Drugs Revenue by Sale Channel (2017-2028)
7.3 Europe Over-The-Counter(OTC) Drugs Market Size by Country
7.3.1 Europe Over-The-Counter(OTC) Drugs Sales by Country (2017-2028)
7.3.2 Europe Over-The-Counter(OTC) Drugs Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Over-The-Counter(OTC) Drugs Market Size by Type
8.1.1 Asia Pacific Over-The-Counter(OTC) Drugs Sales by Type (2017-2028)
8.1.2 Asia Pacific Over-The-Counter(OTC) Drugs Revenue by Type (2017-2028)
8.2 Asia Pacific Over-The-Counter(OTC) Drugs Market Size by Sale Channel
8.2.1 Asia Pacific Over-The-Counter(OTC) Drugs Sales by Sale Channel (2017-2028)
8.2.2 Asia Pacific Over-The-Counter(OTC) Drugs Revenue by Sale Channel (2017-2028)
8.3 Asia Pacific Over-The-Counter(OTC) Drugs Market Size by Region
8.3.1 Asia Pacific Over-The-Counter(OTC) Drugs Sales by Region (2017-2028)
8.3.2 Asia Pacific Over-The-Counter(OTC) Drugs Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Over-The-Counter(OTC) Drugs Market Size by Type
9.1.1 Latin America Over-The-Counter(OTC) Drugs Sales by Type (2017-2028)
9.1.2 Latin America Over-The-Counter(OTC) Drugs Revenue by Type (2017-2028)
9.2 Latin America Over-The-Counter(OTC) Drugs Market Size by Sale Channel
9.2.1 Latin America Over-The-Counter(OTC) Drugs Sales by Sale Channel (2017-2028)
9.2.2 Latin America Over-The-Counter(OTC) Drugs Revenue by Sale Channel (2017-2028)
9.3 Latin America Over-The-Counter(OTC) Drugs Market Size by Country
9.3.1 Latin America Over-The-Counter(OTC) Drugs Sales by Country (2017-2028)
9.3.2 Latin America Over-The-Counter(OTC) Drugs Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Over-The-Counter(OTC) Drugs Market Size by Type
10.1.1 Middle East and Africa Over-The-Counter(OTC) Drugs Sales by Type (2017-2028)
10.1.2 Middle East and Africa Over-The-Counter(OTC) Drugs Revenue by Type (2017-2028)
10.2 Middle East and Africa Over-The-Counter(OTC) Drugs Market Size by Sale Channel
10.2.1 Middle East and Africa Over-The-Counter(OTC) Drugs Sales by Sale Channel (2017-2028)
10.2.2 Middle East and Africa Over-The-Counter(OTC) Drugs Revenue by Sale Channel (2017-2028)
10.3 Middle East and Africa Over-The-Counter(OTC) Drugs Market Size by Country
10.3.1 Middle East and Africa Over-The-Counter(OTC) Drugs Sales by Country (2017-2028)
10.3.2 Middle East and Africa Over-The-Counter(OTC) Drugs Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Bayer
11.1.1 Bayer Corporation Information
11.1.2 Bayer Overview
11.1.3 Bayer Over-The-Counter(OTC) Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Bayer Over-The-Counter(OTC) Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Bayer Recent Developments
11.2 Boehringer Ingelheim
11.2.1 Boehringer Ingelheim Corporation Information
11.2.2 Boehringer Ingelheim Overview
11.2.3 Boehringer Ingelheim Over-The-Counter(OTC) Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Boehringer Ingelheim Over-The-Counter(OTC) Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Boehringer Ingelheim Recent Developments
11.3 GSK
11.3.1 GSK Corporation Information
11.3.2 GSK Overview
11.3.3 GSK Over-The-Counter(OTC) Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 GSK Over-The-Counter(OTC) Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 GSK Recent Developments
11.4 Novartis
11.4.1 Novartis Corporation Information
11.4.2 Novartis Overview
11.4.3 Novartis Over-The-Counter(OTC) Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Novartis Over-The-Counter(OTC) Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Novartis Recent Developments
11.5 Pfizer
11.5.1 Pfizer Corporation Information
11.5.2 Pfizer Overview
11.5.3 Pfizer Over-The-Counter(OTC) Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Pfizer Over-The-Counter(OTC) Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Pfizer Recent Developments
11.6 PGT healthcare
11.6.1 PGT healthcare Corporation Information
11.6.2 PGT healthcare Overview
11.6.3 PGT healthcare Over-The-Counter(OTC) Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 PGT healthcare Over-The-Counter(OTC) Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 PGT healthcare Recent Developments
11.7 Sanofi
11.7.1 Sanofi Corporation Information
11.7.2 Sanofi Overview
11.7.3 Sanofi Over-The-Counter(OTC) Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Sanofi Over-The-Counter(OTC) Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Sanofi Recent Developments
11.8 Teva Pharmaceuticals
11.8.1 Teva Pharmaceuticals Corporation Information
11.8.2 Teva Pharmaceuticals Overview
11.8.3 Teva Pharmaceuticals Over-The-Counter(OTC) Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Teva Pharmaceuticals Over-The-Counter(OTC) Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Teva Pharmaceuticals Recent Developments
11.9 Takeda
11.9.1 Takeda Corporation Information
11.9.2 Takeda Overview
11.9.3 Takeda Over-The-Counter(OTC) Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Takeda Over-The-Counter(OTC) Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Takeda Recent Developments
11.10 Cipla
11.10.1 Cipla Corporation Information
11.10.2 Cipla Overview
11.10.3 Cipla Over-The-Counter(OTC) Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Cipla Over-The-Counter(OTC) Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Cipla Recent Developments
11.11 Sun Pharmaceutical Industries
11.11.1 Sun Pharmaceutical Industries Corporation Information
11.11.2 Sun Pharmaceutical Industries Overview
11.11.3 Sun Pharmaceutical Industries Over-The-Counter(OTC) Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Sun Pharmaceutical Industries Over-The-Counter(OTC) Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Sun Pharmaceutical Industries Recent Developments
11.12 Glenmark
11.12.1 Glenmark Corporation Information
11.12.2 Glenmark Overview
11.12.3 Glenmark Over-The-Counter(OTC) Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Glenmark Over-The-Counter(OTC) Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Glenmark Recent Developments
11.13 Innovus Pharmaceuticals
11.13.1 Innovus Pharmaceuticals Corporation Information
11.13.2 Innovus Pharmaceuticals Overview
11.13.3 Innovus Pharmaceuticals Over-The-Counter(OTC) Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Innovus Pharmaceuticals Over-The-Counter(OTC) Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Innovus Pharmaceuticals Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Over-The-Counter(OTC) Drugs Industry Chain Analysis
12.2 Over-The-Counter(OTC) Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Over-The-Counter(OTC) Drugs Production Mode & Process
12.4 Over-The-Counter(OTC) Drugs Sales and Marketing
12.4.1 Over-The-Counter(OTC) Drugs Sales Channels
12.4.2 Over-The-Counter(OTC) Drugs Distributors
12.5 Over-The-Counter(OTC) Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Over-The-Counter(OTC) Drugs Industry Trends
13.2 Over-The-Counter(OTC) Drugs Market Drivers
13.3 Over-The-Counter(OTC) Drugs Market Challenges
13.4 Over-The-Counter(OTC) Drugs Market Restraints
14 Key Findings in The Global Over-The-Counter(OTC) Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Global Over-The-Counter(OTC) Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Cold and Flu Products
Table 3. Major Manufacturers of Analgesics
Table 4. Major Manufacturers of Dermatological Products
Table 5. Major Manufacturers of Gastrointestinal Products
Table 6. Major Manufacturers of Vitamin
Table 7. Major Manufacturers of Other
Table 8. Global Over-The-Counter(OTC) Drugs Market Size Growth Rate by Sale Channel, 2017 VS 2021 VS 2028 (US$ Million)
Table 9. Global Over-The-Counter(OTC) Drugs Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 10. Global Over-The-Counter(OTC) Drugs Sales by Region (2017-2022) & (K Units)
Table 11. Global Over-The-Counter(OTC) Drugs Sales Market Share by Region (2017-2022)
Table 12. Global Over-The-Counter(OTC) Drugs Sales by Region (2023-2028) & (K Units)
Table 13. Global Over-The-Counter(OTC) Drugs Sales Market Share by Region (2023-2028)
Table 14. Global Over-The-Counter(OTC) Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 15. Global Over-The-Counter(OTC) Drugs Revenue Market Share by Region (2017-2022)
Table 16. Global Over-The-Counter(OTC) Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 17. Global Over-The-Counter(OTC) Drugs Revenue Market Share by Region (2023-2028)
Table 18. Global Over-The-Counter(OTC) Drugs Sales by Manufacturers (2017-2022) & (K Units)
Table 19. Global Over-The-Counter(OTC) Drugs Sales Share by Manufacturers (2017-2022)
Table 20. Global Over-The-Counter(OTC) Drugs Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 21. Global Over-The-Counter(OTC) Drugs Revenue Share by Manufacturers (2017-2022)
Table 22. Over-The-Counter(OTC) Drugs Price by Manufacturers (2017-2022) &(USD/Unit)
Table 23. Global Over-The-Counter(OTC) Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Over-The-Counter(OTC) Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Over-The-Counter(OTC) Drugs as of 2021)
Table 25. Over-The-Counter(OTC) Drugs Manufacturing Base Distribution and Headquarters
Table 26. Manufacturers Over-The-Counter(OTC) Drugs Product Offered
Table 27. Date of Manufacturers Enter into Over-The-Counter(OTC) Drugs Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Over-The-Counter(OTC) Drugs Sales by Type (2017-2022) & (K Units)
Table 30. Global Over-The-Counter(OTC) Drugs Sales by Type (2023-2028) & (K Units)
Table 31. Global Over-The-Counter(OTC) Drugs Sales Share by Type (2017-2022)
Table 32. Global Over-The-Counter(OTC) Drugs Sales Share by Type (2023-2028)
Table 33. Global Over-The-Counter(OTC) Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 34. Global Over-The-Counter(OTC) Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 35. Global Over-The-Counter(OTC) Drugs Revenue Share by Type (2017-2022)
Table 36. Global Over-The-Counter(OTC) Drugs Revenue Share by Type (2023-2028)
Table 37. Over-The-Counter(OTC) Drugs Price by Type (2017-2022) & (USD/Unit)
Table 38. Global Over-The-Counter(OTC) Drugs Price Forecast by Type (2023-2028) & (USD/Unit)
Table 39. Global Over-The-Counter(OTC) Drugs Sales by Sale Channel (2017-2022) & (K Units)
Table 40. Global Over-The-Counter(OTC) Drugs Sales by Sale Channel (2023-2028) & (K Units)
Table 41. Global Over-The-Counter(OTC) Drugs Sales Share by Sale Channel (2017-2022)
Table 42. Global Over-The-Counter(OTC) Drugs Sales Share by Sale Channel (2023-2028)
Table 43. Global Over-The-Counter(OTC) Drugs Revenue by Sale Channel (2017-2022) & (US$ Million)
Table 44. Global Over-The-Counter(OTC) Drugs Revenue by Sale Channel (2023-2028) & (US$ Million)
Table 45. Global Over-The-Counter(OTC) Drugs Revenue Share by Sale Channel (2017-2022)
Table 46. Global Over-The-Counter(OTC) Drugs Revenue Share by Sale Channel (2023-2028)
Table 47. Over-The-Counter(OTC) Drugs Price by Sale Channel (2017-2022) & (USD/Unit)
Table 48. Global Over-The-Counter(OTC) Drugs Price Forecast by Sale Channel (2023-2028) & (USD/Unit)
Table 49. North America Over-The-Counter(OTC) Drugs Sales by Type (2017-2022) & (K Units)
Table 50. North America Over-The-Counter(OTC) Drugs Sales by Type (2023-2028) & (K Units)
Table 51. North America Over-The-Counter(OTC) Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 52. North America Over-The-Counter(OTC) Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 53. North America Over-The-Counter(OTC) Drugs Sales by Sale Channel (2017-2022) & (K Units)
Table 54. North America Over-The-Counter(OTC) Drugs Sales by Sale Channel (2023-2028) & (K Units)
Table 55. North America Over-The-Counter(OTC) Drugs Revenue by Sale Channel (2017-2022) & (US$ Million)
Table 56. North America Over-The-Counter(OTC) Drugs Revenue by Sale Channel (2023-2028) & (US$ Million)
Table 57. North America Over-The-Counter(OTC) Drugs Sales by Country (2017-2022) & (K Units)
Table 58. North America Over-The-Counter(OTC) Drugs Sales by Country (2023-2028) & (K Units)
Table 59. North America Over-The-Counter(OTC) Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 60. North America Over-The-Counter(OTC) Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 61. Europe Over-The-Counter(OTC) Drugs Sales by Type (2017-2022) & (K Units)
Table 62. Europe Over-The-Counter(OTC) Drugs Sales by Type (2023-2028) & (K Units)
Table 63. Europe Over-The-Counter(OTC) Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 64. Europe Over-The-Counter(OTC) Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 65. Europe Over-The-Counter(OTC) Drugs Sales by Sale Channel (2017-2022) & (K Units)
Table 66. Europe Over-The-Counter(OTC) Drugs Sales by Sale Channel (2023-2028) & (K Units)
Table 67. Europe Over-The-Counter(OTC) Drugs Revenue by Sale Channel (2017-2022) & (US$ Million)
Table 68. Europe Over-The-Counter(OTC) Drugs Revenue by Sale Channel (2023-2028) & (US$ Million)
Table 69. Europe Over-The-Counter(OTC) Drugs Sales by Country (2017-2022) & (K Units)
Table 70. Europe Over-The-Counter(OTC) Drugs Sales by Country (2023-2028) & (K Units)
Table 71. Europe Over-The-Counter(OTC) Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 72. Europe Over-The-Counter(OTC) Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 73. Asia Pacific Over-The-Counter(OTC) Drugs Sales by Type (2017-2022) & (K Units)
Table 74. Asia Pacific Over-The-Counter(OTC) Drugs Sales by Type (2023-2028) & (K Units)
Table 75. Asia Pacific Over-The-Counter(OTC) Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 76. Asia Pacific Over-The-Counter(OTC) Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 77. Asia Pacific Over-The-Counter(OTC) Drugs Sales by Sale Channel (2017-2022) & (K Units)
Table 78. Asia Pacific Over-The-Counter(OTC) Drugs Sales by Sale Channel (2023-2028) & (K Units)
Table 79. Asia Pacific Over-The-Counter(OTC) Drugs Revenue by Sale Channel (2017-2022) & (US$ Million)
Table 80. Asia Pacific Over-The-Counter(OTC) Drugs Revenue by Sale Channel (2023-2028) & (US$ Million)
Table 81. Asia Pacific Over-The-Counter(OTC) Drugs Sales by Region (2017-2022) & (K Units)
Table 82. Asia Pacific Over-The-Counter(OTC) Drugs Sales by Region (2023-2028) & (K Units)
Table 83. Asia Pacific Over-The-Counter(OTC) Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 84. Asia Pacific Over-The-Counter(OTC) Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 85. Latin America Over-The-Counter(OTC) Drugs Sales by Type (2017-2022) & (K Units)
Table 86. Latin America Over-The-Counter(OTC) Drugs Sales by Type (2023-2028) & (K Units)
Table 87. Latin America Over-The-Counter(OTC) Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 88. Latin America Over-The-Counter(OTC) Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 89. Latin America Over-The-Counter(OTC) Drugs Sales by Sale Channel (2017-2022) & (K Units)
Table 90. Latin America Over-The-Counter(OTC) Drugs Sales by Sale Channel (2023-2028) & (K Units)
Table 91. Latin America Over-The-Counter(OTC) Drugs Revenue by Sale Channel (2017-2022) & (US$ Million)
Table 92. Latin America Over-The-Counter(OTC) Drugs Revenue by Sale Channel (2023-2028) & (US$ Million)
Table 93. Latin America Over-The-Counter(OTC) Drugs Sales by Country (2017-2022) & (K Units)
Table 94. Latin America Over-The-Counter(OTC) Drugs Sales by Country (2023-2028) & (K Units)
Table 95. Latin America Over-The-Counter(OTC) Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 96. Latin America Over-The-Counter(OTC) Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Over-The-Counter(OTC) Drugs Sales by Type (2017-2022) & (K Units)
Table 98. Middle East and Africa Over-The-Counter(OTC) Drugs Sales by Type (2023-2028) & (K Units)
Table 99. Middle East and Africa Over-The-Counter(OTC) Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Over-The-Counter(OTC) Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Over-The-Counter(OTC) Drugs Sales by Sale Channel (2017-2022) & (K Units)
Table 102. Middle East and Africa Over-The-Counter(OTC) Drugs Sales by Sale Channel (2023-2028) & (K Units)
Table 103. Middle East and Africa Over-The-Counter(OTC) Drugs Revenue by Sale Channel (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Over-The-Counter(OTC) Drugs Revenue by Sale Channel (2023-2028) & (US$ Million)
Table 105. Middle East and Africa Over-The-Counter(OTC) Drugs Sales by Country (2017-2022) & (K Units)
Table 106. Middle East and Africa Over-The-Counter(OTC) Drugs Sales by Country (2023-2028) & (K Units)
Table 107. Middle East and Africa Over-The-Counter(OTC) Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 108. Middle East and Africa Over-The-Counter(OTC) Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 109. Bayer Corporation Information
Table 110. Bayer Description and Major Businesses
Table 111. Bayer Over-The-Counter(OTC) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 112. Bayer Over-The-Counter(OTC) Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 113. Bayer Recent Developments
Table 114. Boehringer Ingelheim Corporation Information
Table 115. Boehringer Ingelheim Description and Major Businesses
Table 116. Boehringer Ingelheim Over-The-Counter(OTC) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 117. Boehringer Ingelheim Over-The-Counter(OTC) Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 118. Boehringer Ingelheim Recent Developments
Table 119. GSK Corporation Information
Table 120. GSK Description and Major Businesses
Table 121. GSK Over-The-Counter(OTC) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 122. GSK Over-The-Counter(OTC) Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 123. GSK Recent Developments
Table 124. Novartis Corporation Information
Table 125. Novartis Description and Major Businesses
Table 126. Novartis Over-The-Counter(OTC) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 127. Novartis Over-The-Counter(OTC) Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 128. Novartis Recent Developments
Table 129. Pfizer Corporation Information
Table 130. Pfizer Description and Major Businesses
Table 131. Pfizer Over-The-Counter(OTC) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 132. Pfizer Over-The-Counter(OTC) Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 133. Pfizer Recent Developments
Table 134. PGT healthcare Corporation Information
Table 135. PGT healthcare Description and Major Businesses
Table 136. PGT healthcare Over-The-Counter(OTC) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 137. PGT healthcare Over-The-Counter(OTC) Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 138. PGT healthcare Recent Developments
Table 139. Sanofi Corporation Information
Table 140. Sanofi Description and Major Businesses
Table 141. Sanofi Over-The-Counter(OTC) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 142. Sanofi Over-The-Counter(OTC) Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 143. Sanofi Recent Developments
Table 144. Teva Pharmaceuticals Corporation Information
Table 145. Teva Pharmaceuticals Description and Major Businesses
Table 146. Teva Pharmaceuticals Over-The-Counter(OTC) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 147. Teva Pharmaceuticals Over-The-Counter(OTC) Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 148. Teva Pharmaceuticals Recent Developments
Table 149. Takeda Corporation Information
Table 150. Takeda Description and Major Businesses
Table 151. Takeda Over-The-Counter(OTC) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 152. Takeda Over-The-Counter(OTC) Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 153. Takeda Recent Developments
Table 154. Cipla Corporation Information
Table 155. Cipla Description and Major Businesses
Table 156. Cipla Over-The-Counter(OTC) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 157. Cipla Over-The-Counter(OTC) Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 158. Cipla Recent Developments
Table 159. Sun Pharmaceutical Industries Corporation Information
Table 160. Sun Pharmaceutical Industries Description and Major Businesses
Table 161. Sun Pharmaceutical Industries Over-The-Counter(OTC) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 162. Sun Pharmaceutical Industries Over-The-Counter(OTC) Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 163. Sun Pharmaceutical Industries Recent Developments
Table 164. Glenmark Corporation Information
Table 165. Glenmark Description and Major Businesses
Table 166. Glenmark Over-The-Counter(OTC) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 167. Glenmark Over-The-Counter(OTC) Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 168. Glenmark Recent Developments
Table 169. Innovus Pharmaceuticals Corporation Information
Table 170. Innovus Pharmaceuticals Description and Major Businesses
Table 171. Innovus Pharmaceuticals Over-The-Counter(OTC) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 172. Innovus Pharmaceuticals Over-The-Counter(OTC) Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 173. Innovus Pharmaceuticals Recent Developments
Table 174. Key Raw Materials Lists
Table 175. Raw Materials Key Suppliers Lists
Table 176. Over-The-Counter(OTC) Drugs Distributors List
Table 177. Over-The-Counter(OTC) Drugs Customers List
Table 178. Over-The-Counter(OTC) Drugs Market Trends
Table 179. Over-The-Counter(OTC) Drugs Market Drivers
Table 180. Over-The-Counter(OTC) Drugs Market Challenges
Table 181. Over-The-Counter(OTC) Drugs Market Restraints
Table 182. Research Programs/Design for This Report
Table 183. Key Data Information from Secondary Sources
Table 184. Key Data Information from Primary Sources
List of Figures
Figure 1. Over-The-Counter(OTC) Drugs Product Picture
Figure 3. Global Over-The-Counter(OTC) Drugs Market Share by Type in 2021 & 2028
Figure 3. Cold and Flu Products Product Picture
Figure 4. Analgesics Product Picture
Figure 5. Dermatological Products Product Picture
Figure 6. Gastrointestinal Products Product Picture
Figure 7. Vitamin Product Picture
Figure 8. Other Product Picture
Figure 9. Global Over-The-Counter(OTC) Drugs Market Share by Sale Channel in 2021 & 2028
Figure 10. Hospital Pharmacy
Figure 11. Retail Pharmacy
Figure 12. Online Pharmacy
Figure 13. Over-The-Counter(OTC) Drugs Report Years Considered
Figure 14. Global Over-The-Counter(OTC) Drugs Sales 2017-2028 (K Units)
Figure 15. Global Over-The-Counter(OTC) Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 16. Global Over-The-Counter(OTC) Drugs Revenue 2017-2028 (US$ Million)
Figure 17. Global Over-The-Counter(OTC) Drugs Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 18. Global Over-The-Counter(OTC) Drugs Sales Market Share by Region (2017-2022)
Figure 19. Global Over-The-Counter(OTC) Drugs Sales Market Share by Region (2023-2028)
Figure 20. North America Over-The-Counter(OTC) Drugs Sales YoY (2017-2028) & (K Units)
Figure 21. North America Over-The-Counter(OTC) Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Europe Over-The-Counter(OTC) Drugs Sales YoY (2017-2028) & (K Units)
Figure 23. Europe Over-The-Counter(OTC) Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Asia-Pacific Over-The-Counter(OTC) Drugs Sales YoY (2017-2028) & (K Units)
Figure 25. Asia-Pacific Over-The-Counter(OTC) Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Latin America Over-The-Counter(OTC) Drugs Sales YoY (2017-2028) & (K Units)
Figure 27. Latin America Over-The-Counter(OTC) Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 28. Middle East & Africa Over-The-Counter(OTC) Drugs Sales YoY (2017-2028) & (K Units)
Figure 29. Middle East & Africa Over-The-Counter(OTC) Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 30. The Over-The-Counter(OTC) Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 31. The Top 5 and 10 Largest Manufacturers of Over-The-Counter(OTC) Drugs in the World: Market Share by Over-The-Counter(OTC) Drugs Revenue in 2021
Figure 32. Global Over-The-Counter(OTC) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 33. Global Over-The-Counter(OTC) Drugs Sales Market Share by Type (2017-2028)
Figure 34. Global Over-The-Counter(OTC) Drugs Revenue Market Share by Type (2017-2028)
Figure 35. Global Over-The-Counter(OTC) Drugs Sales Market Share by Sale Channel (2017-2028)
Figure 36. Global Over-The-Counter(OTC) Drugs Revenue Market Share by Sale Channel (2017-2028)
Figure 37. North America Over-The-Counter(OTC) Drugs Sales Market Share by Type (2017-2028)
Figure 38. North America Over-The-Counter(OTC) Drugs Revenue Market Share by Type (2017-2028)
Figure 39. North America Over-The-Counter(OTC) Drugs Sales Market Share by Sale Channel (2017-2028)
Figure 40. North America Over-The-Counter(OTC) Drugs Revenue Market Share by Sale Channel (2017-2028)
Figure 41. North America Over-The-Counter(OTC) Drugs Sales Share by Country (2017-2028)
Figure 42. North America Over-The-Counter(OTC) Drugs Revenue Share by Country (2017-2028)
Figure 43. U.S. Over-The-Counter(OTC) Drugs Revenue (2017-2028) & (US$ Million)
Figure 44. Canada Over-The-Counter(OTC) Drugs Revenue (2017-2028) & (US$ Million)
Figure 45. Europe Over-The-Counter(OTC) Drugs Sales Market Share by Type (2017-2028)
Figure 46. Europe Over-The-Counter(OTC) Drugs Revenue Market Share by Type (2017-2028)
Figure 47. Europe Over-The-Counter(OTC) Drugs Sales Market Share by Sale Channel (2017-2028)
Figure 48. Europe Over-The-Counter(OTC) Drugs Revenue Market Share by Sale Channel (2017-2028)
Figure 49. Europe Over-The-Counter(OTC) Drugs Sales Share by Country (2017-2028)
Figure 50. Europe Over-The-Counter(OTC) Drugs Revenue Share by Country (2017-2028)
Figure 51. Germany Over-The-Counter(OTC) Drugs Revenue (2017-2028) & (US$ Million)
Figure 52. France Over-The-Counter(OTC) Drugs Revenue (2017-2028) & (US$ Million)
Figure 53. U.K. Over-The-Counter(OTC) Drugs Revenue (2017-2028) & (US$ Million)
Figure 54. Italy Over-The-Counter(OTC) Drugs Revenue (2017-2028) & (US$ Million)
Figure 55. Russia Over-The-Counter(OTC) Drugs Revenue (2017-2028) & (US$ Million)
Figure 56. Asia Pacific Over-The-Counter(OTC) Drugs Sales Market Share by Type (2017-2028)
Figure 57. Asia Pacific Over-The-Counter(OTC) Drugs Revenue Market Share by Type (2017-2028)
Figure 58. Asia Pacific Over-The-Counter(OTC) Drugs Sales Market Share by Sale Channel (2017-2028)
Figure 59. Asia Pacific Over-The-Counter(OTC) Drugs Revenue Market Share by Sale Channel (2017-2028)
Figure 60. Asia Pacific Over-The-Counter(OTC) Drugs Sales Share by Region (2017-2028)
Figure 61. Asia Pacific Over-The-Counter(OTC) Drugs Revenue Share by Region (2017-2028)
Figure 62. China Over-The-Counter(OTC) Drugs Revenue (2017-2028) & (US$ Million)
Figure 63. Japan Over-The-Counter(OTC) Drugs Revenue (2017-2028) & (US$ Million)
Figure 64. South Korea Over-The-Counter(OTC) Drugs Revenue (2017-2028) & (US$ Million)
Figure 65. India Over-The-Counter(OTC) Drugs Revenue (2017-2028) & (US$ Million)
Figure 66. Australia Over-The-Counter(OTC) Drugs Revenue (2017-2028) & (US$ Million)
Figure 67. China Taiwan Over-The-Counter(OTC) Drugs Revenue (2017-2028) & (US$ Million)
Figure 68. Indonesia Over-The-Counter(OTC) Drugs Revenue (2017-2028) & (US$ Million)
Figure 69. Thailand Over-The-Counter(OTC) Drugs Revenue (2017-2028) & (US$ Million)
Figure 70. Malaysia Over-The-Counter(OTC) Drugs Revenue (2017-2028) & (US$ Million)
Figure 71. Latin America Over-The-Counter(OTC) Drugs Sales Market Share by Type (2017-2028)
Figure 72. Latin America Over-The-Counter(OTC) Drugs Revenue Market Share by Type (2017-2028)
Figure 73. Latin America Over-The-Counter(OTC) Drugs Sales Market Share by Sale Channel (2017-2028)
Figure 74. Latin America Over-The-Counter(OTC) Drugs Revenue Market Share by Sale Channel (2017-2028)
Figure 75. Latin America Over-The-Counter(OTC) Drugs Sales Share by Country (2017-2028)
Figure 76. Latin America Over-The-Counter(OTC) Drugs Revenue Share by Country (2017-2028)
Figure 77. Mexico Over-The-Counter(OTC) Drugs Revenue (2017-2028) & (US$ Million)
Figure 78. Brazil Over-The-Counter(OTC) Drugs Revenue (2017-2028) & (US$ Million)
Figure 79. Argentina Over-The-Counter(OTC) Drugs Revenue (2017-2028) & (US$ Million)
Figure 80. Middle East and Africa Over-The-Counter(OTC) Drugs Sales Market Share by Type (2017-2028)
Figure 81. Middle East and Africa Over-The-Counter(OTC) Drugs Revenue Market Share by Type (2017-2028)
Figure 82. Middle East and Africa Over-The-Counter(OTC) Drugs Sales Market Share by Sale Channel (2017-2028)
Figure 83. Middle East and Africa Over-The-Counter(OTC) Drugs Revenue Market Share by Sale Channel (2017-2028)
Figure 84. Middle East and Africa Over-The-Counter(OTC) Drugs Sales Share by Country (2017-2028)
Figure 85. Middle East and Africa Over-The-Counter(OTC) Drugs Revenue Share by Country (2017-2028)
Figure 86. Turkey Over-The-Counter(OTC) Drugs Revenue (2017-2028) & (US$ Million)
Figure 87. Saudi Arabia Over-The-Counter(OTC) Drugs Revenue (2017-2028) & (US$ Million)
Figure 88. UAE Over-The-Counter(OTC) Drugs Revenue (2017-2028) & (US$ Million)
Figure 89. Over-The-Counter(OTC) Drugs Value Chain
Figure 90. Over-The-Counter(OTC) Drugs Production Process
Figure 91. Channels of Distribution
Figure 92. Distributors Profiles
Figure 93. Bottom-up and Top-down Approaches for This Report
Figure 94. Data Triangulation
Figure 95. Key Executives Interviewed
